Clinical Trial Update: A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment [NA]

View source ↗

Summary

A feasibility study sponsored by King's College London aims to identify the most appropriate digital dietary assessment tool for obesity patients initiating GLP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GLP-1 receptor agonist (class) (glucagon-like peptide-1 receptor agonist)

Snippet

Sponsor: King's College London | Conditions: Obese Patients | NA | Status: ENROLLING_BY_INVITATION